 effect granulocyt colony-stimul factor neutropenia due non-hodgkin lymphoma author recombin human granulocyt colony-stimul factor rhg-csf patient advanc non-hodgkin lymphoma combin chemotherapi group patient day rhg-csf intraven infus day day chemotherapi strong linear relationship dose area curv dose rang rhg-csf serum mean half-lif hour second phase patient dose day durat neutropenia durat fever rhg-csf clinic observ rhg-csf administr slight bone pain studi optimum dose rhg-csf patient chemotherapi studi rhg-csf use drug patient myelosuppress chemotherapi